Hims & Hers' acquisition of Trybe Labs broadens its treatment range and enhances its competitive edge through increased data ...

Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%. Read why I downgrade HIMS stock from buy to ...

A company called Ro (formerly Roman) has a model similar to Hims’s; Amazon has an online pharmacy and telehealth business. In the past several years, Hims has steadily expanded its business into ...

Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks ...

Shares of Hims & Hers Health Inc (NYSE: HIMS) are flying higher on Wednesday. The company's stock gained 21.7% as of 2:00 p.m ...

In today’s world, erectile dysfunction (ED) affects millions of men, causing emotional and psychological distress.

BofA raised the firm’s price target on Hims & Hers to $21 from $18 and keeps an Underperform rating on the shares. The firm increased Q4 ...

Both companies offer different ED treatments and a similar business model, but what are the differences between BlueChew and Hims, and which one might be right for you? Founded in 2017 ...

Per management, HIMS’ model is rapidly gaining scale, thereby driving top-line growth, improving profitability and strong cash flow. On theearnings call management confirmed that the company ...

Established in 2017, Hims & Hers Health (NYSE ... and personal care solutions through a convenient direct-to-consumer model. Since going public via a special purpose acquisition company (SPAC ...